Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pediatric Brain Tumor Consortium phase 1 study of CD40 agonist sotigalimab in pediatric and young adult patients with recurrent CNS tumors and newly-diagnosed DIPG.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

A modular and flexible pipeline for intraoperative electrode reconstruction and localization in patients with brain lesions.

Frontiers in neural circuits·2026
Same author

Late cerebrospinal fluid shunt infections: a Hydrocephalus Clinical Research Network study.

Journal of neurosurgery. Pediatrics·2026
Same author

MYCN drives pediatric glioma transformation from neural progenitors and creates distinct therapeutic vulnerabilities.

Cell reports·2026
Same author

Outcomes following radiotherapy for atypical teratoid/rhabdoid tumor in combination with surgery and intensive chemotherapy: A report from Children's Oncology Group study ACNS0333.

Neuro-oncology pediatrics·2026
Same author

Developing a core outcome set for the NeuroPoint Alliance Quality Outcomes Database Pediatric Tumor Surgery Registry: a modified Delphi study.

Journal of neuro-oncology·2026
Same journal

RETRACTED: Sabir et al. DNA Based and Stimuli-Responsive Smart Nanocarrier for Diagnosis and Treatment of Cancer: Applications and Challenges. <i>Cancers</i> 2021, <i>13</i>, 3396.

Cancers·2026
Same journal

Correction: Adeluola et al. Chemoprevention of 4-NQO-Induced Oral Cancer by the Combination of Resveratrol and EGCG: In Vivo, In Silico and In Vitro Studies. <i>Cancers</i> 2026, <i>18</i>, 1098.

Cancers·2026
Same journal

Correction: Peñalver et al. Guidelines for Diagnosis, Treatment, and Follow-Up of Patients with Follicular Lymphoma-Spanish Lymphoma Group (GELTAMO) 2026. <i>Cancers</i> 2026, <i>18</i>, 395.

Cancers·2026
Same journal

Correction: Accorsi Buttini et al. Development of a Simplified Geriatric Score-4 (SGS-4) to Predict Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Patients Aged over 50. <i>Cancers</i> 2025, <i>17</i>, 3278.

Cancers·2026
Same journal

Age-Stratified Long-Term Outcomes of Immune Checkpoint Inhibitors for Stage IV Melanoma and NSCLC in The Netherlands: A Population-Based Study.

Cancers·2026
Same journal

Targeting Ferroptosis in Glioblastoma: Molecular Mechanisms, Tumor Microenvironment, and Therapeutic Opportunities.

Cancers·2026
See all related articles

Related Experiment Video

Updated: Dec 22, 2025

Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions
07:39

Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions

Published on: November 17, 2021

3.8K

Pediatric Low-Grade Gliomas.

Kelly L Collins1, Ian F Pollack1

  • 1Department of Pediatric Neurosurgery, University of Pittsburgh, Pittsburgh, PA 15224, USA.

Cancers
|May 8, 2020
PubMed
Summary
This summary is machine-generated.

Pediatric low-grade gliomas are common pediatric brain tumors. Advances in molecular understanding and targeted therapies are improving treatment outcomes for these challenging childhood cancers.

Keywords:
BRAF mutationdiffuse astrocytomamolecularly-targeted therapyneuroepithelial tumorpediatric low-grade gliomapilocytic astrocytomapleomorphic xanthoastrocytomasubependymal giant cell astrocytoma

More Related Videos

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG
08:46

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG

Published on: March 7, 2017

17.4K
A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas
06:27

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas

Published on: May 9, 2025

970

Related Experiment Videos

Last Updated: Dec 22, 2025

Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions
07:39

Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions

Published on: November 17, 2021

3.8K
A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG
08:46

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG

Published on: March 7, 2017

17.4K
A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas
06:27

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas

Published on: May 9, 2025

970

Area of Science:

  • Pediatric oncology
  • Neuro-oncology
  • Molecular genetics

Background:

  • Pediatric brain tumors are a leading cause of cancer mortality in children.
  • Pediatric low-grade gliomas (pLGGs) are the most frequent central nervous system tumors in children, distinct from adult gliomas.
  • Recent advances have elucidated the molecular and genetic landscape of pLGGs.

Purpose of the Study:

  • To review the current classification of pediatric low-grade gliomas.
  • To discuss histopathologic and radiographic features of pLGGs.
  • To summarize current and emerging therapeutic strategies for pediatric low-grade gliomas.

Main Methods:

  • Review of current literature on pediatric low-grade gliomas.
  • Analysis of classification systems, diagnostic features, and treatment modalities.
  • Inclusion of data from clinical trials on novel therapies.

Main Results:

  • Pediatric low-grade gliomas exhibit unique characteristics compared to adult gliomas.
  • Integrated phenotypic and genotypic parameters guide tailored therapy.
  • Molecular-directed therapies, advanced neuroimaging, and radiation techniques enhance outcomes.

Conclusions:

  • Understanding the molecular basis of pLGGs is crucial for personalized treatment.
  • Multimodal treatment approaches, including surgery, chemotherapy, and targeted therapies, are evolving.
  • Ongoing clinical trials are investigating novel therapeutic agents for pediatric low-grade gliomas.